Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process.
[gs_wpposts theme="gs_wppost_grid_1" cols="3" num="46" group="resources"]
Sign up to our newsletter today, to get access to the latest company and industry news
© 2025 Magnitude Biosciences Ltd. All rights reserved.
